Although the study did not find any CYP2C9 variants associated with highly diminished THC metabolism, most of these patients do carry genetic variants that predisposes them to the potential development of psychosis and memory impairment, especially with higher concentrations and/or longer durations of THC use. The gene discussed is CYP2C9; the disease is psychotic disorder.